Moreover, blocking CCL4 inhibited the increase of memory CD8+ T cells (Figure 8D) and tumor-specific CD8+ T cells (Figure 8E) mediated by the combination of CBDCA and anti-PD-1 antibodies in the 4T1 tumors, as well as other two models. Here, CCL4 is linked to neoplasm.